Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Erytech Pharma SA ADR stock
Learn how to easily invest in Erytech Pharma SA ADR stock.
Erytech Pharma SA ADR is a biotechnology business based in the US. Erytech Pharma SA ADR shares (ERYP) are listed on the NASDAQ and all prices are listed in US Dollars. Erytech Pharma SA ADR employs 149 staff and has a trailing 12-month revenue of around $2.9 million.
How to buy shares in Erytech Pharma SA ADR
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ERYP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Erytech Pharma SA ADR stock price (NASDAQ: ERYP)Use our graph to track the performance of ERYP stocks over time.
Erytech Pharma SA ADR shares at a glance
|Latest market close||$0.62|
|52-week range||$0.50 - $6.31|
|50-day moving average||$0.95|
|200-day moving average||$1.41|
|Wall St. target price||$3.01|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.81|
Buy Erytech Pharma SA ADR shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Erytech Pharma SA ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Erytech Pharma SA ADR price performance over time
|1 week (2022-09-29)||14.11%|
|1 month (2022-09-07)||-28.43%|
|3 months (2022-07-07)||-47.11%|
|6 months (2022-04-07)||-57.50%|
|1 year (2021-10-07)||-90.08%|
|2 years (2020-10-07)||-89.93%|
|3 years (2019-10-03)||4.22|
|5 years (2017-10-03)||N/A|
Erytech Pharma SA ADR financials
|Revenue TTM||$2.9 million|
|Gross profit TTM||$4.2 million|
|Return on assets TTM||-43.23%|
|Return on equity TTM||-91.39%|
|Market capitalisation||$17.2 million|
TTM: trailing 12 months
Erytech Pharma SA ADR share dividends
We're not expecting Erytech Pharma SA ADR to pay a dividend over the next 12 months.
Erytech Pharma SA ADR share price volatility
Over the last 12 months, Erytech Pharma SA ADR's shares have ranged in value from as little as $0.5 up to $6.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Erytech Pharma SA ADR's is 1.5301. This would suggest that Erytech Pharma SA ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Erytech Pharma SA ADR overview
ERYTECH Pharma S. A. , a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-"-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France. .
Erytech Pharma SA ADR in the news
Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
ERYTECH Provides Business and Financial Update for the First Half of 2022
Frequently asked questionsWhat percentage of Erytech Pharma SA ADR is owned by institutions?
Currently 4.856% of Erytech Pharma SA ADR shares are held by institutions. How many people work for Erytech Pharma SA ADR?
Latest data suggests 149 work at Erytech Pharma SA ADR. When does the fiscal year end for Erytech Pharma SA ADR?
Erytech Pharma SA ADR's fiscal year ends in December. Where is Erytech Pharma SA ADR based?
Erytech Pharma SA ADR's address is: 60 Avenue Rockefeller, Lyon, France, 69008 What is Erytech Pharma SA ADR's ISIN number?
Erytech Pharma SA ADR's international securities identification number is: US29604W1080 What is Erytech Pharma SA ADR's CUSIP number?
Erytech Pharma SA ADR's Committee on Uniform Securities Identification Procedures number is: 29604W108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert